Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002421314 | SCV002678785 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-08-30 | criteria provided, single submitter | clinical testing | The p.Q271R variant (also known as c.812A>G), located in coding exon 5 of the CTNNA1 gene, results from an A to G substitution at nucleotide position 812. The glutamine at codon 271 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004572379 | SCV005058585 | uncertain significance | Patterned macular dystrophy 2 | 2024-01-25 | criteria provided, single submitter | clinical testing |